Home Blog
Genomics Medicine Ireland (GMI), the recently-acquired Irish subsidiary of WuXi NextCode, said today it has opened a research clinic in Dublin’s City Centre hub, with the goal of advancing precision medicine research and discovery in Ireland. The new research clinic will enable the expansion of Ireland’s first large-scale research study into the role of genetics on fitness and health. The...
Statistics can be a great tool for analyzing datasets and it can also be a sobering means to provide a stark reality. For instance, recent data suggests that approximately every three minutes one person in the United States is diagnosed with some form of blood cancer. While this statistic shows that we still have a long way to go...
Thermo Fisher Scientific will combine its liquid chromatography-mass spectrometry (LC-MS) instrumentation with NX Prenatal’s NeXosome platform to develop proteomics assays designed to offer noninvasive risk assessments of pregnancy outcomes, through a collaboration whose value was not disclosed. The collaboration aims to develop diagnostics to monitor fetal health in utero and assess the risk of adverse outcomes, including preterm birth and...
A pair of companies specializing in applying computing to genomics said today they will make their products available via Google Cloud Platform, through partnerships whose values were not disclosed. Genomenon said its Cited Variants Reference (CVR) data will be available through a public dataset in BigQuery, Google Cloud's big data and machine learning data warehouse, for genomic applications. CVR is designed...
The AI platform from Notable completed personalized treatment recommendations for all 20 patients within 30 days demonstrating both a positive and negative predictive value average of 84 percent.
DNA mutation with green wrench twisting a red nut
A new algorithm analyzes patterns in mutational profiles to identify cancer patients with underlying defects in DNA repair machinery, guiding targeted therapies.
Clinico-genomic research study aims to improve personalized treatments for people with multiple sclerosis DNAnexus, UPMC, and Sutter Health network said today they have launched a large-scale clinico-genomic multiple sclerosis (MS) research study aimed at improving personalized treatments for people with the group of 30+ inherited neuromuscular diseases. Under the collaboration, whose value was not disclosed, researchers at the Sutter Health Center...
Colon cancer. Cancer attacking cell. Colon disease concept
CRC tumors can switch off expression of a cell surface molecule that is a key target of immunotherapy, thus preventing the treatment from working.
Sophia Genetics has obtained the CE-IVD marking for its Solid Tumor Solution (STS), a molecular diagnostic application designed to precisely detect and characterize all types of genomic alterations in 42 clinically relevant genes associated with a range of solid tumors. Those solid tumors include lung, colorectal, skin and brain cancers. According to Sophia Genetics, the STS panel can detect single nucleotide...
Evotec and Individumed said today they will partner to develop new precision therapeutics for colorectal cancer (CRC), through a collaboration whose value was not disclosed. Over an initial two-year period, the companies plan to use Evotec’s PanHunter bioinformatics analysis platform and its small molecule and antibody discovery platforms, as well as the CRC cohort of Indivumed’s IndivuType global multi-omics cancer...
Scroll Up